Clinical Trials in Denver

Showing 3161-3180 of 8,669 trials

Evaluation of Product Performance of a New Silicone Hydrogel Multifocal Contact Lens

NCT05660577

The objective of this study is to evaluate the product performance of a new silicone hydrogel daily disposable multifocal contact lens, the Bausch + Lomb (kalifilcon A) Daily Disposable Multifocal Contact Lens, when worn by current soft contact lens wearers on a daily disposable wear basis

Myopia and Hyperopia and Presbyopia

Bausch & Lomb Incorporated301 participantsStarted Nov 2022

San Diego, California, United States • San Francisco, California, United States • Denver, Colorado, United States +17 more locations

COMPLETEDPhase 3< 1 mile

Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)

NCT03409107

The purpose of this multi-center study in non-dialysis participants with anemia associated with CKD is to evaluate safety, efficacy and quality of life of daprodustat compared to placebo.

Anaemia

GlaxoSmithKline614 participantsStarted Mar 2018

Homewood, Alabama, United States • Little Rock, Arkansas, United States • Downey, California, United States +165 more locations

Evaluation of Product Performance of a New Silicone Hydrogel Multifocal Contact Lens

Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)

Find Trials by Condition in Denver

A Study of Repotrectinib in Combination With Other Anticancer Therapies for the Treatment of Subjects With KRAS-Mutant Solid Tumors

Open-Label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome

Adaptation of Insulin Delivery Settings to Improve Clinical Outcomes With AID Use

A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts

Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)

An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-2)

Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies Avalglucosidase Alfa and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease

A SAD/MAD to Assess the Safety, PK/PD of FT-4202 in Healthy Volunteers and Sickle Cell Disease Patients

TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)

Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPA

Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain

A Study to Compare the Efficacy and Safety of Lisocabtagene Maraleucel vs Investigator's Choice Options in Adult Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Whose Disease Has Failed Treatment With Both BTKi and BCL2i Therapies

Stories for Change: Early Detection Can Save Lives

Safety and Effectiveness Study of the Zenflow Spring System

Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)

Study of PF-07263689 in Participants With Selected Advanced Solid Tumors

Phase I/IIa Study of H002 in NSCLC With Active EGFR Mutation

A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract